Gultekin Melis, Esen Caglayan Selenge Beduk, Akgor Utku, Salman Mehmet Coskun, Tuncel Murat, Ozmen Mustafa, Yildiz Ferah
Department of Radiation Oncology, Hacettepe University Medical School, Ankara, Turkey.
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
J Contemp Brachytherapy. 2020 Apr;12(2):175-180. doi: 10.5114/jcb.2020.92997. Epub 2020 Feb 11.
Primary vaginal cancer and pelvic organ prolapse (POP) combination is extremely rare. Although definitive chemoradiotherapy (CRT) and brachytherapy (BT) is the standard treatment for advanced stage primary vaginal cancer, there is a limited data about the treatment of primary vaginal cancer combined with POP due to its rarity. In addition, radiotherapy (RT) process may be difficult in these cases and often result in more toxicity.
In this case report, we present a 77-year-old woman with a diagnosis of primary vaginal cancer associated with POP, who was treated with definitive CRT using a pessary to restore vaginal anatomy for optimal radiation. Following CRT, complete response was observed and vaginal cuff BT was performed. The patient tolerated the treatment very well and is still alive without disease at 10-months follow-up.
Combined primary vaginal cancer and POP is an extremely rare clinical entity, with only a few cases reported in the literature. When applying CRT in these cases, critical organ doses may be higher than expected due to the downward descent of the pelvic organs. Especially in elderly patients, a pessary can be used as a non-surgical procedure to restore the anatomy for symptom relief during definitive CRT. Additionally, it allows tumors to be targeted more precisely.
原发性阴道癌与盆腔器官脱垂(POP)合并极为罕见。尽管根治性放化疗(CRT)和近距离放疗(BT)是晚期原发性阴道癌的标准治疗方法,但由于其罕见性,关于原发性阴道癌合并POP的治疗数据有限。此外,在这些病例中放疗(RT)过程可能困难,且常导致更多毒性。
在本病例报告中,我们介绍了一名77岁诊断为原发性阴道癌合并POP的女性,她接受了根治性CRT治疗,使用子宫托恢复阴道解剖结构以实现最佳放疗。CRT后观察到完全缓解,并进行了阴道残端BT。患者对治疗耐受良好,在10个月的随访中无疾病存活。
原发性阴道癌与POP合并是一种极为罕见的临床实体,文献中仅有少数病例报道。在这些病例中应用CRT时,由于盆腔器官向下移位,关键器官剂量可能高于预期。特别是在老年患者中,子宫托可作为一种非手术方法,在根治性CRT期间恢复解剖结构以缓解症状。此外,它还能更精确地靶向肿瘤。